- ISIN
- CA0717051076
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- May 6, 2022
Highlights
- Market Cap
- $6.04B
- Enterprise Value
- $5.76B
- EPS (TTM)
- -$0.48
- Total Revenue (TTM)
- $5.32B
- Gross Profit (TTM)
- $3.01B
- EBITDA (TTM)
- $641.00M
- Year Range
- $13.53 - $18.92
- Target Price
- $18.33
- ROA (TTM)
- -1.23%
- ROE (TTM)
- -2.68%
- Avg. Volume (1M)
- 447K
- Avg. Volume Value (1M)
- $7.36M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BLCO Performance Chart
Bausch + Lomb Corp (BLCO) is down 1.0% since the beginning of the year. At $17 per share, BLCO is trading 10.6% below its 52-week high of $19.
Loading charts...
Compare this symbol against anything
Returns By Period
Bausch + Lomb Corp (BLCO) has returned -1.00% so far this year and 25.26% over the past 12 months.
Bausch + Lomb Corp
- 1D
- -0.47%
- 1M
- -1.46%
- 6M
- 1.26%
- YTD
- -1.00%
- 1Y
- 25.26%
- 3Y*
- -4.39%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -2.10%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
BLCO Monthly Returns History
Based on dividend-adjusted daily data since May 6, 2022, BLCO's average daily return is +0.02%, while the average monthly return is +0.21%. At this rate, an investment would double in approximately 27.5 years.
Historically, 49% of months were positive and 51% were negative. The best month was Jul 2024 with a return of +18.6%, while the worst month was Apr 2025 at -20.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, BLCO closed higher 49% of trading days. The best single day was Sep 16, 2024 with a return of +14.5%, while the worst single day was Apr 30, 2025 at -15.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.22% | 9.58% | -13.11% | 0.00% | -1.57% | 5.81% | 2.11% | -1.00% | |||||
| 2025 | -3.93% | -7.78% | -9.38% | -20.28% | -0.78% | 13.43% | 4.77% | 7.34% | 3.01% | -0.86% | 8.37% | 5.50% | -5.43% |
| 2024 | -17.88% | 17.77% | 4.85% | -15.95% | 5.50% | -5.35% | 18.60% | -4.59% | 17.41% | 5.13% | -2.27% | -8.88% | 5.86% |
| 2023 | 11.15% | 1.16% | -0.17% | 0.29% | 2.29% | 12.37% | -1.00% | -9.76% | -5.47% | -4.78% | -4.52% | 10.71% | 9.99% |
| 2022 | -8.05% | -10.41% | -5.58% | 3.41% | 3.09% | -7.04% | 6.10% | 2.51% | -16.16% |
Benchmark Metrics
Bausch + Lomb Corp has an annualized alpha of -10.19%, beta of 1.07, and R2 of 0.20 versus S&P 500 Index. Calculated based on daily prices since May 06, 2022.
- This stock participated in 124.04% of S&P 500 Index downside but only 55.25% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.20 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -10.19%
- Beta
- 1.07
- R²
- 0.20
- Upside Capture
- 55.25%
- Downside Capture
- 124.04%
Return for Risk
Risk / Return Rank
BLCO ranks 68 for risk / return — above 68% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Bausch + Lomb Corp (BLCO) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BLCO | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.65 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.25 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.20 | 2.00 | -0.80 |
| Martin ratioReturn relative to average drawdown | 2.61 | 8.49 | -5.89 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Bausch + Lomb Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bausch + Lomb Corp was 48.07%, occurring on May 6, 2025. The portfolio has not yet recovered.
The current Bausch + Lomb Corp drawdown is 19.44%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-48.07%May 2025 | 1y 9mo | — | 3y 21dJul 2023 - now | 2025 selloff2025 |
-33.20%Jun 2022 | 1mo 5d | 1y 17d | 1y 1moMay 2022 - Jun 2023 | Bear market2022 |
-3.83%Jul 2023 | 6d | 2d | 8dJul 2023 - Jul 2023 | — |
Drawdown Indicators
| BLCO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.07% | -56.78% | +8.71% |
Max Drawdown (1Y)Largest decline over 1 year | -20.11% | -9.10% | -11.01% |
Max Drawdown (3Y)Largest decline over 3 years | -47.92% | -18.90% | -29.02% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -19.44% | -1.58% | -17.86% |
Average DrawdownAverage peak-to-trough decline | -21.77% | -10.70% | -11.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.26% | 2.14% | +7.12% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bausch + Lomb Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Bausch + Lomb Corp is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BLCO relative to other companies in the Medical Instruments & Supplies industry. Currently, BLCO has a P/S ratio of 1.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BLCO in comparison with other companies in the Medical Instruments & Supplies industry. Currently, BLCO has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BLCO
Add Bausch + Lomb Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BLCO